Clinical Trial Update: Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage [Phase 4]

View source ↗

Summary

This entry reports a Phase 4 clinical trial evaluating intravitreal ranibizumab for treating vitreous hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Vitreous Hemorrhage

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Hospital Regional de São José - Dr. Homero de Miranda Gomes | Conditions: Diabetic Retinopathy, Vitreous Hemorrhage | Phase 4 | Status: UNKNOWN